Company Filing History:
Years Active: 1996-1998
Title: Innovations and Contributions of Barry S. Schonwetter
Introduction
Barry S. Schonwetter is a notable inventor based in Philadelphia, PA, recognized for his contributions to the field of antimicrobial peptides. With three patents to his name, Schonwetter's innovations have significant implications for medical treatments and health sciences.
Latest Patents
One of Schonwetter's latest patents is focused on an inducible antimicrobial peptide known as lingual antimicrobial peptide (LAP). This invention details a peptide that demonstrates both antibacterial and antifungal activity, sourced from mammalian epithelium. The patent provides comprehensive information regarding the prepro- and pro-precursors of LAP, as well as the coding cDNA that facilitates its production. Furthermore, the invention includes methods for effectively treating microbial infections of the epithelia by utilizing purified LAP or by promoting the endogenous production of LAP through various components.
Career Highlights
Barry S. Schonwetter's work primarily involves his role at Magainin Pharmaceuticals, Inc., where he has been able to push the boundaries of research in antimicrobial treatments. His expertise distinguishes him as a leading inventor in the biotechnology field. His focus on antimicrobial peptides highlights a significant area of medical research that directly addresses pressing health challenges.
Collaborations
Throughout his career, Schonwetter has collaborated with esteemed individuals like Michael A. Zasloff. This partnership has likely enriched his innovative approaches and contributed to the success of their joint research initiatives.
Conclusion
As an inventor, Barry S. Schonwetter continues to make impactful contributions to the field of antimicrobial research. His patents not only demonstrate his ingenuity but also position him as a key player in the advancement of medical treatments targeting microbial infections. Through his work, he illustrates the vital role inventors play in enhancing public health and developing new therapeutic solutions.